Inventor
TAMBURINI PAUL P
US27 patents
⚠️ This page may combine multiple inventors who share the name “TAMBURINI PAUL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALEXION PHARMA INC
21 patentsUS9079949B1Jul 14, 2015
Anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC182 citations99
US9663574B2May 30, 2017
Anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC24 citations98
US9206251B2Dec 8, 2015
Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC36 citations98
US9107861B1Aug 18, 2015
Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC58 citations98
US11434280B2Sep 6, 2022
Anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC10 citations94
US10584164B2Mar 10, 2020
Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies
ALEXION PHARMA INC11 citations94
US10227400B2Mar 12, 2019
Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies
ALEXION PHARMA INC14 citations94
US9803007B1Oct 31, 2017
Anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC14 citations92
US9371377B2Jun 21, 2016
Anti-C5 antibodies having improved pharmacokinetics
ALEXION PHARMA INC22 citations92
US9221901B2Dec 29, 2015
Methods of treating complement-associated disorders with anti-C5a antibodies
ALEXION PHARMA INC11 citations92
US9469690B2Oct 18, 2016
Methods of treating complement-associated disorders with anti-C5a antibodies
ALEXION PHARMA INC4 citations84
US9434784B1Sep 6, 2016
Nucleic acids encodng anti-C5A antibodies
ALEXION PHARMA INC4 citations84
US9371378B1Jun 21, 2016
Anti-C5a antibodies
ALEXION PHARMA INC7 citations84
US9309310B2Apr 12, 2016
Nucleic acids encoding anti-C5a antibodies
ALEXION PHARMA INC7 citations84
US10450370B2Oct 22, 2019
Anti-C5a antibodies
ALEXION PHARMA INC2 citations73
US9963503B2May 8, 2018
Methods of producing anti-C5a antibodies
ALEXION PHARMA INC2 citations73
US11498960B2Nov 15, 2022
Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
ALEXION PHARMA INC2 citations68
US11407821B2Aug 9, 2022
Anti-C5A antibodies
ALEXION PHARMA INC0 citations62
US12497445B2Dec 16, 2025
Monovalent anti-properdin antibodies and antibody fragments
ALEXION PHARMA INC0 citations59
US12221473B2Feb 11, 2025
Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
ALEXION PHARMA INC1 citations59
US11198725B2Dec 14, 2021
Monovalent anti-properdin antibodies and antibody fragments
ALEXION PHARMA INC0 citations59